Wave life sciences announces approval of first clinical trial application for restoraation-2 trial of wve-006 in individuals with alpha-1 antitrypsin deficiency (aatd)

Proof-of-mechanism data for wve-006 in individuals with aatd remain on track for 2024 proof-of-mechanism data for wve-006 in individuals with aatd remain on track for 2024

WVE Ratings Summary

WVE Quant Ranking